*The following content is generated by AI and is for reference only.
Overview
Entecavir intermediate (ETB) is a key pharmaceutical building block for the synthesis of Entecavir, a potent antiviral agent. The core process involves specific chiral resolution and nucleophilic substitution reactions to ensure high purity.
- Molecular Formula: C10H17N5O2
- CAS Number: 148910-66-3
Application
- Viral Hepatitis Treatment: Primary precursor for manufacturing Entecavir tablets targeting chronic hepatitis B virus (HBV) infection.
- API Manufacturing: Used by pharmaceutical manufacturers in bulk active pharmaceutical ingredient production lines.
- R&D Synthesis: Employed in research facilities for developing novel analogs with improved pharmacokinetic profiles.
Precautions
- Storage: Must be stored in a cool, dry, well-ventilated area away from direct sunlight and moisture.
- Safety: Requires personal protective equipment (PPE) during handling to avoid skin contact and inhalation of dust.
- Regulatory: Intended solely for industrial use; not for direct clinical administration without further processing.